Drug Detail:Teprotumumab (Teprotumumab [ tep-roe-toom-ue-mab ])
Drug Class: Growth hormone receptor blockers
Drug Detail:Teprotumumab (Teprotumumab [ tep-roe-toom-ue-mab ])
Drug Class: Growth hormone receptor blockers
Initial dose: 10 mg/kg intravenously
Maintenance dose: 20 mg/kg intravenously every 3 weeks for 7 additional infusions
Use: Treatment of thyroid eye disease
Data not available
Data not available
CONTRAINDICATIONS: None
Safety and efficacy have not been established in patients younger than 18 years.
This drug is not recommended for use in children.
Consult WARNINGS section for additional precautions.
Data not available
Administration advice: